FDA DEVICE FACTS
RhythmStar System (SL)
RhythMedix, LLC
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The RhythmStar SL System is intended for use by patients who either have or are at risk of having cardiac disease and those who demonstrate intermittent symptoms indicative of cardiac disease and require cardiac monitoring on a continuing basis. The device continuously records ECG data and, upon detection by an ECG analysis algorithm or when manually initiated by the patient, automatically delivers all recorded cardiac activity to the cloud server, where it is presented and can be reviewed by a medical professional at a monitoring center. RhythmStar SL is not intended for real-time monitoring. The data received from RhythmStar SL can be used for retrospective review, arrhythmia analysis, and further evaluation, reporting and signal measurements using the RhythmStar System. RhythmStar SL is not intended to sound any alarms. The device does not deliver any therapy, administer any drugs, or provide life support. RhythmStar SL does not provide interpretive or diagnostic statements. Interpretation and diagnosis are the responsibility of a physician. RhythmStar SL is for prescription use only.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。